{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:48:28Z","timestamp":1786992508660,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.micpath.2020.104236","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:40:56Z","timestamp":1588542056000},"page":"104236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"special_numbering":"C","title":["Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-0975","authenticated-orcid":false,"given":"Parismita","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya K.","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-8045","authenticated-orcid":false,"given":"Kam Y.J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-289X","authenticated-orcid":false,"given":"Timir","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104236_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2020.104236_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2020.104236_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcv.2003.08.004","article-title":"Early diagnosis of SARS coronavirus infection by real time RT-PCR","volume":"28","author":"Poon","year":"2003","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104236_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.micpath.2020.104236_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.micpath.2020.104236_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2020.104236_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","volume":"64","author":"Martinez","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104236_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.micpath.2020.104236_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.micpath.2020.104236_bib10","series-title":"Information for Clinicians on Therapeutic Options for COVID-19 Patients","author":"Anonymous","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib11","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2020.104236_bib12","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2020.104236_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 vaccine pipeline: an overview","author":"Chen","year":"2020","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.micpath.2020.104236_bib14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1586\/erv.09.43","article-title":"SARS vaccines: where are we?","volume":"8","author":"Roper","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2020.104236_bib15","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.micpath.2020.104236_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","author":"Thanh Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2020.104236_bib17","series-title":"Moderna's work on a potential vaccine against COVID-19","author":"Anonymous","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib18","series-title":"NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins","author":"Anonymous","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/d41587-020-00005-z","article-title":"The pandemic pipeline","author":"Hodgson","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2020.104236_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.micpath.2020.104236_bib21","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.micpath.2020.104236_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micpath.2020.104236_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.micpath.2020.104236_bib24","series-title":"Design of Multi Epitope-Based Peptide Vaccine against E Protein of Human 2019-nCoV: an Immunoinformatics Approach","author":"Abdelmageed","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib25","first-page":"1","article-title":"Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach","volume":"n\/a","author":"Bhattacharya","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2020.104236_bib26","article-title":"T Cell epitope-based vaccine design for pandemic novel coronavirus 2019-nCoV","author":"Mishra","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.micpath.2020.104236_bib27","series-title":"The First Coronavirus Drug Candidate Is Set for Testing in China","author":"Mukerjee","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib28","series-title":"Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2020.104236_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijbiomac.2019.07.024","article-title":"Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach","volume":"138","author":"Kalita","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2020.104236_bib31","series-title":"National Public Radio: News and Analysis","article-title":"Mystery in Wuhan: recovered coronavirus patients test negative then positive","author":"Feng","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib32","series-title":"Some Recovered Coronavirus Patients in Wuhan Are Testing Positive Again","author":"Beau","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-020-00938-0","article-title":"We need to be alert: scientists fear second coronavirus wave as China\u2019s lockdowns ease","author":"Cyranoski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2020.104236_bib34","series-title":"DRAFT Landscape of COVID-19 Candidate Vaccines \u2013 21 March 2020","author":"WHO","year":"2020"},{"key":"10.1016\/j.micpath.2020.104236_bib35","article-title":"T cell epitope-based vaccine design for pandemic novel coronavirus 2019-nCoV","author":"Seema","year":"2020","journal-title":"ChemRxiv"},{"issue":"5","key":"10.1016\/j.micpath.2020.104236_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065045","article-title":"Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging","volume":"8","author":"Chang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2020.104236_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV--a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2020.104236_bib38","doi-asserted-by":"crossref","first-page":"44875","DOI":"10.1038\/srep44875","article-title":"Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein","volume":"7","author":"Al-Amri","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.micpath.2020.104236_bib39","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1073\/pnas.1914677117","article-title":"Improved protein structure prediction using predicted interresidue orientations","volume":"117","author":"Yang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"updated-by":[{"DOI":"10.1016\/j.micpath.2020.104401","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000}}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020305234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020305234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T06:50:58Z","timestamp":1613803858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020305234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":39,"alternative-id":["S0882401020305234"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104236","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202003.0433.v1","asserted-by":"object"}]},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104236"}}